PlainRecalls
FDA Drug Critical Class I Terminated

Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502

Reported: December 28, 2016 Initiated: August 1, 2016 #D-0228-2017

Product Description

Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502

Reason for Recall

Non-Sterility; microbial contamination identified as Bacillus circulans

Details

Units Affected
12 vials
Distribution
MA, NY, NJ & FL; Canada
Location
Ridgewood, NJ

Frequently Asked Questions

What product was recalled?
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502. Recalled by Town and Country Compounding and Consultation Services. Units affected: 12 vials.
Why was this product recalled?
Non-Sterility; microbial contamination identified as Bacillus circulans
Which agency issued this recall?
This recall was issued by the FDA Drug on December 28, 2016. Severity: Critical. Recall number: D-0228-2017.